Volibo R 0.2/1MG Tab

Tablet

Type 2 diabetes mellitus to improve post‑meal and overall blood glucose control when diet and exercise alone are insufficient; used when dual therapy is advised by the doctor.

Voglibose is an alpha‑glucosidase inhibitor that delays carbohydrate digestion and absorption in the intestine, reducing post‑meal glucose spikes. Repaglinide is a meglitinide that stimulates the pancreas to release insulin in a glucose‑dependent manner, mainly controlling post‑prandial blood sugar.

Oral tablet. Take exactly as prescribed. Generally taken just before meals (0–30 minutes before); if a meal is skipped, the dose is usually skipped to reduce hypoglycaemia risk. Follow diet/exercise advice and monitor blood glucose.

Hypoglycaemia, abdominal pain, flatulence, diarrhoea, nausea, headache, dizziness, weight gain, increased liver enzymes

May cause hypoglycaemia (especially if you skip/delay meals, take with other antidiabetics, or drink alcohol); carry glucose source. Use caution in liver impairment; periodic liver function monitoring may be advised. Not recommended in type 1 diabetes or diabetic ketoacidosis. GI side effects (gas/diarrhoea) are common due to voglibose. Inform doctor about recurrent hypoglycaemia, heart disease, kidney/liver problems, or if you are elderly. Seek medical help for severe allergic reaction or persistent abdominal symptoms.

Other antidiabetics/insulin (additive hypoglycaemia), gemfibrozil (markedly increases repaglinide levels—avoid/contraindicated), clopidogrel (increases repaglinide exposure—avoid/caution), azole antifungals/macrolides (may increase repaglinide), rifampicin (may reduce repaglinide effect), beta‑blockers (may mask hypoglycaemia symptoms), corticosteroids/thyroid hormones/diuretics (may raise glucose), alcohol (increases hypoglycaemia risk)

Store below 25°C in a cool, dry place. Protect from moisture and light. Keep out of reach of children.

Repaglinide 1 mg + Voglibose 0.2 mg tablets (other brands), Prandial 0.2/1 Tablet, Repag V 0.2/1 Tablet, Repasure V 0.2/1 Tablet, Ryzodeg? (Not a substitute)